Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature. 2023;615(7950):158-167 - PMID: 36634707 - PMCID: PMC10171827 - DOI: 10.1038/s41586-023-05704-6
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.
Science. 2023;381(6657):515-524 - PMID: 37535729 - PMCID: PMC10755760 - DOI: 10.1126/science.ade2292
Effects of periodontitis on cancer outcomes in the era of immunotherapy.
Lancet Healthy Longev. 2023;4(4):e166-e175 - PMID: 37003275 - PMCID: PMC10148268 - DOI: 10.1016/S2666-7568(23)00021-1
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop.
J Immunother Cancer. 2023;11(6):ePub - PMID: 37290925 - PMCID: PMC10254706 - DOI: 10.1136/jitc-2023-006773
4
CSV